Pseudoephedrine - Important Safety Information from Marketing Authorisation Holders of products containing pseudoephedrine as approved by the HPRA (09.02.24)

Notice type: 3rd Party Publications

Date: 09/02/2024

Important Safety Information from Marketing Authorisation Holders of products containing pseudoephedrine – Risks of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)